Parameter
| Biomarker | MDA | Full name | Malondialdehyde | Molecular Type | Lipid oxidation products |
|---|---|---|---|---|---|
| Molecular Formula | C₃H₄O₂ | Molecular Weight | 72.06 | Core Functional Dimensions | Research phase, monitoring |
| Disease | Metabolic Syndrome | Disease Subtypes | / | ||
| Organ | Systemic/Cells | Test Sample / Technology Platform | Serum/urine (TBA colorimetry, LC-MS/MS) | ||
| Pathobiological Mechanisms | Oxidative stress cause lipid peroxidation, damage biofilms, aggravate metabolic abnormalities | ||||
| Clinical Availability Status | The research phase: reflect the level of oxidative stress, positively related to the MetS progress | ||||
| Notes and Dynamics | Combined with SOD and GSH, the redox status can be comprehensively evaluated | ||||